Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 85.00
0.00 (0.00%)
Aug 27, 2026, 2:17 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 6.71 billion as of August 26, 2026. Its market cap has decreased by -29.07% in one year.
Market Cap
6.71B
Enterprise Value
5.40B
Revenue
615.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.00
ChartMarket Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 6.71B, an increase of 1,327.23%. That is a compound annual growth rate of 19.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 6.71B | -7.86% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 8.52B |
| StemCell Institute | 7.80B |
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.35B |
| CellSource | 7.07B |
| ADR Biomedical Holdings | 6.82B |
| Chordia Therapeutics | 6.34B |
| Noile-Immune Biotech | 6.29B |